Hapten-protein binding:: from theory to practical application in the in vitro prediction of skin sensitization

被引:163
作者
Divkovic, M [1 ]
Pease, CK
Gerberick, GF
Basketter, DA
机构
[1] Unilever Colworth, Safety & Environm Assurance Ctr, Colworth House, Sharnbrook MK44 1LQ, Beds, England
[2] Procter & Gamble Co, Cincinnati, OH USA
关键词
hapten-protein binding; in vitro assay; peptide binding; skin sensitization;
D O I
10.1111/j.0105-1873.2005.00683.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
In view of the forthcoming European Union ban on in vivo testing of cosmetic and toiletry ingredients, following the publication of the 7th amendment to the Cosmetics Directive, the search for practical, alternative, non-animal approaches is gathering pace. For the end-point of skin sensitization, the ultimate goal, i.e. the development and validation of alternative in vitro/in silico assays by 2013, may be achieved through a better understanding of the skin sensitization process on the cellular and molecular levels. One of the key molecular events in skin sensitization is protein haptenation, i.e. the chemical modification of self-skin protein(s) thus forming macromolecular immunogens. This concept is widely accepted and in theory can be used to explain the sensitizing capacity of many known skin sensitizers. Thus, the principle of protein or peptide haptenation could be used in in vitro assays to predict the sensitization potential of a new chemical entity. In this review, we consider some of the theoretical aspects of protein haptenation, how mechanisms of protein haptenation can be investigated experimentally and how we can use such knowledge in the development of novel, alternative approaches for predicting skin sensitization potential in the future.
引用
收藏
页码:189 / 200
页数:12
相关论文
共 68 条
[11]   Dichloronitrobenzene: A reappraisal of its skin sensitization potential [J].
Basketter, DA ;
Scholes, EW ;
Fielding, I ;
Dearman, RJ ;
Hilton, J ;
Kimber, I .
CONTACT DERMATITIS, 1996, 34 (01) :55-58
[12]   Measurement of allergenic potency using the local lymph node assay [J].
Basketter, DA ;
Gerberick, GF ;
Kimber, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2001, 22 (06) :264-265
[13]   THE BINDING OF 5-FLUOROURACIL TO NATIVE AND MODIFIED HUMAN SERUM-ALBUMIN - UV, CD, AND H-1 AND F-19 NMR INVESTIGATION [J].
BERTUCCI, C ;
ASCOLI, G ;
UCCELLOBARRETTA, G ;
DIBARI, L ;
SALVADORI, P .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (09) :1087-1093
[14]   Stable acetaldehyde-protein adducts as biomarkers of alcohol exposure [J].
Birt, JEEC ;
Shuker, DEG ;
Farmer, PB .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (02) :136-142
[15]   IDENTIFICATION OF LYS(190)AS THE PRIMARY BINDING-SITE FOR PYRIDOXAL 5'-PHOSPHATE IN HUMAN SERUM-ALBUMIN [J].
BOHNEY, JP ;
FONDA, ML ;
FELDHOFF, RC .
FEBS LETTERS, 1992, 298 (2-3) :266-268
[16]   Implication of the MAPK pathways in the maturation of human dendritic cells induced by nickel and TNF-α [J].
Boislève, F ;
Kerdine-Römer, S ;
Pallardy, M .
TOXICOLOGY, 2005, 206 (02) :233-244
[17]   Dendritic cells as a tool for the predictive identification of skin sensitisation hazard - The report and recommendations of ECVAM workshop 51 [J].
Casati, S ;
Aeby, P ;
Basketter, DA ;
Cavani, A ;
Gennari, A ;
Gerberick, GF ;
Griem, P ;
Hartung, T ;
Kimber, I ;
Lepoittevin, JP ;
Meade, BJ ;
Pallardy, M ;
Rougier, N ;
Rousset, F ;
Rubinstenn, G ;
Sallusto, F ;
Verheyen, GR ;
Zuang, V .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2005, 33 (01) :47-62
[18]   Human and mouse proteomic databases: novel resources in the protein universe [J].
Celis, JE ;
Ostergaard, M ;
Jensen, NA ;
Gromova, I ;
Rasmussen, HH ;
Gromov, P .
FEBS LETTERS, 1998, 430 (1-2) :64-72
[19]   GROWTH INHIBITORY AND BIOCIDAL ACTIVITY OF SOME ISOTHIAZOLONE BIOCIDES [J].
COLLIER, PJ ;
RAMSEY, AJ ;
AUSTIN, P ;
GILBERT, P .
JOURNAL OF APPLIED BACTERIOLOGY, 1990, 69 (04) :569-577
[20]   CHEMICAL-REACTIVITY OF SOME ISOTHIAZOLONE BIOCIDES [J].
COLLIER, PJ ;
RAMSEY, A ;
WAIGH, RD ;
DOUGLAS, KT ;
AUSTIN, P ;
GILBERT, P .
JOURNAL OF APPLIED BACTERIOLOGY, 1990, 69 (04) :578-584